Recent Advances of Eosinophils and Its Correlated Diseases

Overview

Journal Front Public Health

Specialty Public Health

Date 2022 Aug 12

PMID 35958837

Authors

Zhang Tao

Hua Zhu

Jiateng Zhang

Zhiming Huang

Ze Xiang

Tu Hong

Affiliations

Soon will be listed here.

Abstract

Eosinophils are differentiated by bone marrow multipotent progenitor cells and are further released into peripheral blood after maturation. Human eosinophils can exhibit unique multi-leaf nuclear morphology, which are filled with cytoplasmic granules that contain cytotoxicity and immune regulatory proteins. In recent years, many studies focused on the origin, differentiation and development process of eosinophils. It has been discovered that the eosinophils have the regulatory functions of innate and adaptive immunity, and can also function in several diseases, including asthma, chronic obstructive pulmonary diseases, acute respiratory distress syndrome, malignant tumors and so on. Hence, the role and effects of eosinophils in various diseases are emphasized. In this review, we comprehensively summarized the development and differentiation process of eosinophils, the research progress of their related cytokines, diseases and current clinical treatment options, and discussed the potential drug target, aiming to provide a theoretical and practical basis for the clinical prevention and treatment of eosinophil-related diseases, especially respiratory diseases. To conclude, the guiding significance of future disease treatment is proposed based on the recent updated understandings into the cell functions of eosinophils.

Citing Articles

Association of peripheral eosinophil count with chronic kidney disease progression risk: a retrospective cohort study in Chinese population.

Ren Y, Zhang J, Hu X, Yu R, Tu Q, Li Y Ren Fail. 2024; 46(2):2394164.

PMID: 39212259 PMC: 11370690. DOI: 10.1080/0886022X.2024.2394164.

Eosinophilic Patterns in Patients with Seasonal Allergy Affected by Bronchial Asthma and Rhinitis/Rhinosinusitis: Efficacy of Benralizumab in Patients with the Persistent Pattern.

DAiuto V, Mormile I, Granata F, Romano A, Della Casa F, DOnofrio C J Clin Med. 2024; 13(3).

PMID: 38337448 PMC: 10856349. DOI: 10.3390/jcm13030754.

Recent advances of bioresponsive polymeric nanomedicine for cancer therapy.

Hong T, Shen X, Syeda M, Zhang Y, Sheng H, Zhou Y Nano Res. 2022; 16(2):2660-2671.

PMID: 36405982 PMC: 9664041. DOI: 10.1007/s12274-022-5002-2.

References

Pazdrak K, Adachi T, Alam R . Src homology 2 protein tyrosine phosphatase (SHPTP2)/Src homology 2 phosphatase 2 (SHP2) tyrosine phosphatase is a positive regulator of the interleukin 5 receptor signal transduction pathways leading to the prolongation of eosinophil survival. J Exp Med. 1997; 186(4):561-8. PMC: 2199030. DOI: 10.1084/jem.186.4.561. View

Shalit M, Sekhsaria S, Malech H . Modulation of growth and differentiation of eosinophils from human peripheral blood CD34+ cells by IL5 and other growth factors. Cell Immunol. 1995; 160(1):50-7. DOI: 10.1016/0008-8749(95)80008-7. View

Robinson D, Damia R, Zeibecoglou K, Molet S, North J, Yamada T . CD34(+)/interleukin-5Ralpha messenger RNA+ cells in the bronchial mucosa in asthma: potential airway eosinophil progenitors. Am J Respir Cell Mol Biol. 1998; 20(1):9-13. DOI: 10.1165/ajrcmb.20.1.3449. View

Bristol J, Zhu M, Ji H, Mina M, Xie Y, Clarke L . In vitro and in vivo activities of an oncolytic adenoviral vector designed to express GM-CSF. Mol Ther. 2003; 7(6):755-64. DOI: 10.1016/s1525-0016(03)00103-5. View

Rothenberg M . Eosinophilic gastrointestinal disorders (EGID). J Allergy Clin Immunol. 2004; 113(1):11-28. DOI: 10.1016/j.jaci.2003.10.047. View

Punnonen J, Aversa G, Cocks B, McKenzie A, Menon S, Zurawski G . Interleukin 13 induces interleukin 4-independent IgG4 and IgE synthesis and CD23 expression by human B cells. Proc Natl Acad Sci U S A. 1993; 90(8):3730-4. PMC: 46375. DOI: 10.1073/pnas.90.8.3730. View

Stoeckle C, Simon H . CD8(+) T cells producing IL-3 and IL-5 in non-IgE-mediated eosinophilic diseases. Allergy. 2014; 68(12):1622-5. DOI: 10.1111/all.12311. View

Barker R, Gleich G, Pease L . Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J Exp Med. 1988; 168(4):1493-8. PMC: 2189086. DOI: 10.1084/jem.168.4.1493. View

Rosenberg H . Eosinophil-Derived Neurotoxin (EDN/RNase 2) and the Mouse Eosinophil-Associated RNases (mEars): Expanding Roles in Promoting Host Defense. Int J Mol Sci. 2015; 16(7):15442-55. PMC: 4519907. DOI: 10.3390/ijms160715442. View

10.

Zhang C, Yi W, Li F, Du X, Wang H, Wu P . Eosinophil-derived CCL-6 impairs hematopoietic stem cell homeostasis. Cell Res. 2018; 28(3):323-335. PMC: 5835778. DOI: 10.1038/cr.2018.2. View

11.

Xia L, Hua W, Jin Y, Tian B, Qiu Z, Zhang C . Eosinophil differentiation in the bone marrow is promoted by protein tyrosine phosphatase SHP2. Cell Death Dis. 2016; 7:e2175. PMC: 4855658. DOI: 10.1038/cddis.2016.74. View

12.

Kouro T, Takatsu K . IL-5- and eosinophil-mediated inflammation: from discovery to therapy. Int Immunol. 2009; 21(12):1303-9. DOI: 10.1093/intimm/dxp102. View

13.

Bousquet J, Jeffery P, Busse W, Johnson M, Vignola A . Asthma. From bronchoconstriction to airways inflammation and remodeling. Am J Respir Crit Care Med. 2000; 161(5):1720-45. DOI: 10.1164/ajrccm.161.5.9903102. View

14.

Pazdrak K, Moon Y, Straub C, Stafford S, Kurosky A . Eosinophil resistance to glucocorticoid-induced apoptosis is mediated by the transcription factor NFIL3. Apoptosis. 2016; 21(4):421-31. PMC: 4769953. DOI: 10.1007/s10495-016-1226-5. View

15.

El-Shazly A, Masuyama K, Nakano K, Eura M, Samejima Y, Ishikawa T . Human eotaxin induces eosinophil-derived neurotoxin release from normal human eosinophils. Int Arch Allergy Immunol. 1998; 117 Suppl 1:55-8. DOI: 10.1159/000053573. View

16.

Wang Z, DiDonato J, Buffa J, Comhair S, Aronica M, Dweik R . Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma. J Biol Chem. 2016; 291(42):22118-22135. PMC: 5063994. DOI: 10.1074/jbc.M116.750034. View

17.

Johnston L, Hsu C, Krier-Burris R, Chhiba K, Chien K, McKenzie A . IL-33 Precedes IL-5 in Regulating Eosinophil Commitment and Is Required for Eosinophil Homeostasis. J Immunol. 2016; 197(9):3445-3453. PMC: 5101160. DOI: 10.4049/jimmunol.1600611. View

18.

Cayrol C, Girard J . IL-33: an alarmin cytokine with crucial roles in innate immunity, inflammation and allergy. Curr Opin Immunol. 2014; 31:31-7. DOI: 10.1016/j.coi.2014.09.004. View

19.

Pavlidis S, Takahashi K, Ng Kee Kwong F, Xie J, Hoda U, Sun K . "T2-high" in severe asthma related to blood eosinophil, exhaled nitric oxide and serum periostin. Eur Respir J. 2018; 53(1). DOI: 10.1183/13993003.00938-2018. View

20.

Wu Y, Chen H, Xuan N, Zhou L, Wu Y, Zhu C . Induction of ferroptosis-like cell death of eosinophils exerts synergistic effects with glucocorticoids in allergic airway inflammation. Thorax. 2020; 75(11):918-927. DOI: 10.1136/thoraxjnl-2020-214764. View